News Focus
News Focus
icon url

joev2

02/01/24 4:05 PM

#40499 RE: joev2 #40498

I'll also mention that back in the day Conv D's were the big thing for smallcaps. They may still be. And so a company like Sint needs 5 million. A company like Maxim, offers to buy enough shares that equal 5 mil but there are caveats. It generally went something like this: Take the last 15 days of trading and then the 5 lowest closes of those 15. Avg the closing price of those 5 and then we'll buy at a 10-20% discount to that avg.
As you can see the o/s adds up. It was in THOSE types of deals where a Maxim might not be allowed to short any for x amount of time. This all brings me to what we have in Sint-land today. Is it that Maxim won't even take the chance themselves? Have things changed in the micro cap world where Conv D's don't exist or don't exist as much, and instead we have what we have between Sint and Maxim? I simply don't know.
icon url

boston745

02/01/24 5:07 PM

#40500 RE: joev2 #40498

the kickbacks for ALL related parties in this


Kickbacks for all involved including you and other bashers on social media? TA is that you?
I find it interesting that you like to divert the subject away from the hfunds to Maxim and Sonny, why is that? Why would Sonny need kickbacks? Hes got multiple sources of income coming in. Like income from Misssouri S&T which is connected to his R&D efforts there for Sintx and Zimmer, obviously his salary from Sintx for his Chairman/CEO/CFO positions, and any other contract work he does as a materials scientists, medical implant design, work as a lawyer, etc...

You've acknowledged that Sintx has the products, it has the stakeholders, so why would Sonny work to get kickbacks from naked shorting his company? Why would he take that risk? With the value of the products wouldn't it be more lucrative to see the stock price increase to reflect that value, not decrease; including for these same hfunds. The only time this isnt more lucrative is when the products are not viable, which isnt the case here, or there is another agenda afoot. If Sonny is receiving Kickbacks as you suggest why would he bother with shareholder rights offerings to help try to protect his longterm shareholders? Shareholder rights offerings means he expects to eventually reach a state where the stockprice will rise. Thats not a guarantee of course but does mean something. The holder(s) of the 26 preferred shares remaining from the 2020 rights offering should now have a conversion price of .225 if the 10% discount is still applied converting to 115k shares now up from 19,000 last year before the 100:1 RS.

If Sintx is stuck in this cycle of offerings and naked shorting then its logical to wait for Sonny and the board to buy shares as thats likely the sign this cycle is finally coming to an end. Means sufficient news to drive momentum upwards instead of down? As i keep repeating though i think people should be buying 100 shares to hold for potential shareholder rights offerings. One thing that seems to be universal of all the posts bashing Sintx, is there is a goal to drive investors away. This is done to maintain control over the stock and keep driving the price lower. I still believe theres a larger reason for this as nothing moves this up. Not the increasing revenue, nor new sources of revenue are coming online, more patents are being awarded, more grants are being awarded for more product development, nor any of the other things being done to generate value for Sintx.

Sonny just keeps lining up potential revenue generating products which i assume is for the eventual day this is acquired.

========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.


https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779